JP2013178260A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013178260A5 JP2013178260A5 JP2013087048A JP2013087048A JP2013178260A5 JP 2013178260 A5 JP2013178260 A5 JP 2013178260A5 JP 2013087048 A JP2013087048 A JP 2013087048A JP 2013087048 A JP2013087048 A JP 2013087048A JP 2013178260 A5 JP2013178260 A5 JP 2013178260A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- treatment
- acid molecule
- protein
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0606096.6 | 2006-03-27 | ||
| GBGB0606096.6A GB0606096D0 (en) | 2006-03-27 | 2006-03-27 | Screening method |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009502200A Division JP5528103B2 (ja) | 2006-03-27 | 2007-03-27 | スクリーニング法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013178260A JP2013178260A (ja) | 2013-09-09 |
| JP2013178260A5 true JP2013178260A5 (enExample) | 2014-01-30 |
| JP6017367B2 JP6017367B2 (ja) | 2016-10-26 |
Family
ID=36384256
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009502200A Expired - Fee Related JP5528103B2 (ja) | 2006-03-27 | 2007-03-27 | スクリーニング法 |
| JP2013087048A Expired - Fee Related JP6017367B2 (ja) | 2006-03-27 | 2013-04-18 | スクリーニング法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009502200A Expired - Fee Related JP5528103B2 (ja) | 2006-03-27 | 2007-03-27 | スクリーニング法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8784806B2 (enExample) |
| EP (3) | EP2733491B1 (enExample) |
| JP (2) | JP5528103B2 (enExample) |
| AT (1) | ATE537445T1 (enExample) |
| DK (2) | DK2005162T3 (enExample) |
| ES (3) | ES2376912T3 (enExample) |
| GB (1) | GB0606096D0 (enExample) |
| WO (1) | WO2007110623A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1751115A4 (en) | 2004-05-23 | 2010-10-20 | Gerard M Housey | THERAMUTEINMODULATOREN |
| EP2502649A1 (en) | 2005-02-03 | 2012-09-26 | TopoTarget UK Limited | Combination therapy using HDAC inhibitors and erlotinib for treating cancer |
| ATE542527T1 (de) | 2005-05-13 | 2012-02-15 | Topotarget Uk Ltd | Pharmazeutische formulierungen von hdac-hemmern |
| CA2627923C (en) | 2005-11-10 | 2016-01-12 | Topotarget Uk Limited | Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer |
| GB0606096D0 (en) | 2006-03-27 | 2006-05-03 | Cbmm Sa | Screening method |
| US8642809B2 (en) | 2007-09-25 | 2014-02-04 | Topotarget Uk Ltd. | Methods of synthesis of certain hydroxamic acid compounds |
| WO2014164775A1 (en) * | 2013-03-11 | 2014-10-09 | Pioneer Hi-Bred International, Inc. | Methods and compositions to improve the spread of chemical signals in plants |
| GB201306339D0 (en) * | 2013-04-08 | 2013-05-22 | Isis Innovation | Biomarkers for prognosis |
| GB2524519B (en) * | 2014-03-25 | 2019-11-06 | Pelago Bioscience AB | Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay |
| ES2702432B2 (es) | 2017-08-31 | 2019-08-05 | Venegas Pedro Manuel Medina | Método y dispositivo para el análisis de ácidos nucleicos |
| GB201914517D0 (en) * | 2019-10-08 | 2019-11-20 | Randox Laboratories Ltd | Xbp1 isoform multiplex assay |
| CA3258625A1 (en) * | 2022-07-27 | 2024-02-01 | E-Therapeutics Plc | ZPI INHIBITANT DOUBLE-STRANDED NUCLEIC ACID COMPOUNDS |
| CN116949169B (zh) * | 2023-07-31 | 2024-02-06 | 山东大学齐鲁医院 | Smek1在缺血性脑卒中诊治中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050123896A1 (en) * | 2001-10-25 | 2005-06-09 | Benz Christopher C. | Screening system for modulators of her2 mediated transcription and her2 modulators identified thereby |
| US20030186903A1 (en) * | 2001-11-23 | 2003-10-02 | Isis Pharmaceuticals Inc. | Antisense modulation of MyD88 expression |
| US20050118596A1 (en) | 2002-02-08 | 2005-06-02 | Asselbergs Fredericus Alphonsus M. | Method for screening for compounds having hdac inhibitory activity |
| US20040132825A1 (en) * | 2002-03-04 | 2004-07-08 | Bacopoulos Nicholas G. | Methods of treating cancer with HDAC inhibitors |
| BR0316737A (pt) | 2002-11-27 | 2005-12-13 | Irm Llc | Métodos e composições para induzir apoptose em células cancerosas |
| CA2519320A1 (en) * | 2003-02-19 | 2004-09-02 | Astellas Pharma Inc. | Method of estimating antitumor effect of histone deacetylase inhibitor |
| CA2535889A1 (en) * | 2003-08-29 | 2005-03-17 | Aton Pharma, Inc. | Combination methods of treating cancer |
| GB0401876D0 (en) * | 2004-01-28 | 2004-03-03 | Vereniging Het Nl Kanker I | New use for cancer antigen |
| US8193332B2 (en) * | 2004-04-09 | 2012-06-05 | Genecare Research Institute Co., Ltd. | Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| CN1985007A (zh) * | 2004-04-15 | 2007-06-20 | 罗斯塔英法美蒂克斯有限责任公司 | 鉴定介导活细胞对药物响应的基因的方法 |
| WO2006020016A2 (en) * | 2004-07-19 | 2006-02-23 | Schering Corporation | Myd88 as a therapeutic target for cancer |
| CN102605066A (zh) * | 2004-12-08 | 2012-07-25 | 安万特药物公司 | 测量对多西他赛抗药性或敏感性的方法 |
| EP1996935B1 (en) * | 2006-02-23 | 2011-09-14 | Yale University | Drug resistance to plant alkaloids based upon myd88 status in a cell and methods of inhibiting signaling through the tlr-4:myd88 pathway |
| GB0606096D0 (en) | 2006-03-27 | 2006-05-03 | Cbmm Sa | Screening method |
-
2006
- 2006-03-27 GB GBGB0606096.6A patent/GB0606096D0/en not_active Ceased
-
2007
- 2007-03-27 AT AT07732147T patent/ATE537445T1/de active
- 2007-03-27 US US12/294,603 patent/US8784806B2/en active Active
- 2007-03-27 ES ES07732147T patent/ES2376912T3/es active Active
- 2007-03-27 JP JP2009502200A patent/JP5528103B2/ja not_active Expired - Fee Related
- 2007-03-27 DK DK07732147.9T patent/DK2005162T3/da active
- 2007-03-27 DK DK13194854.9T patent/DK2733491T3/en active
- 2007-03-27 EP EP13194854.9A patent/EP2733491B1/en not_active Not-in-force
- 2007-03-27 ES ES13194854.9T patent/ES2607753T3/es active Active
- 2007-03-27 ES ES11162743.6T patent/ES2569663T3/es active Active
- 2007-03-27 EP EP07732147A patent/EP2005162B1/en not_active Not-in-force
- 2007-03-27 EP EP11162743.6A patent/EP2365335B1/en not_active Not-in-force
- 2007-03-27 WO PCT/GB2007/001086 patent/WO2007110623A2/en not_active Ceased
-
2013
- 2013-04-18 JP JP2013087048A patent/JP6017367B2/ja not_active Expired - Fee Related
-
2014
- 2014-06-16 US US14/306,137 patent/US9347103B2/en not_active Expired - Fee Related
-
2016
- 2016-04-29 US US15/143,435 patent/US10012652B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013178260A5 (enExample) | ||
| KR101582321B1 (ko) | 심장성 부정맥의 위험 관리를 위한 유전적 마커 | |
| JP5650871B1 (ja) | そう痒を伴う疾患に罹患した患者のｉｌ−３１アンタゴニストによる治療に対する応答を予測する方法 | |
| CN109837340B (zh) | 用于肺癌无创诊断的外周血基因标记物 | |
| KR20150090246A (ko) | 암을 위한 분자 진단 테스트 | |
| CN105543408B (zh) | 冠心病早期诊断标志物 | |
| JP2012501452A5 (enExample) | ||
| CN109996895A (zh) | 体外诊断精神障碍的方法和生物标志物 | |
| JP2013508719A5 (enExample) | ||
| CN105506083B (zh) | Capg在制备诊断帕金森症产品中的用途 | |
| WO2016042114A1 (en) | Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis | |
| CN105695622B (zh) | Pilra基因作为诊断骨质疏松症的分子标志物 | |
| JP2020531439A (ja) | アトピー性皮膚炎の治療及び治療選択のための組成物及び方法 | |
| CN105567862B (zh) | Cdk18在制备诊断冠心病产品中的用途 | |
| CN104962657B (zh) | Yap1基因在阿尔茨海默病诊治中的应用 | |
| JP2009523004A5 (enExample) | ||
| US20140221235A1 (en) | Biomarker algorithm for determining the time of stroke symptom onset and method | |
| CN105018484B (zh) | Crtap基因及其表达产物作为阿尔茨海默病的诊治靶标 | |
| JP7821416B2 (ja) | アトピー性皮膚炎の診断方法 | |
| JP2014506117A (ja) | 軽度の炎症を検出するための方法 | |
| WO2011066527A1 (en) | Zinc status biomarker materials and related methods | |
| KR20190084061A (ko) | 설파메톡사졸 및/또는 트라이메토프림에 의해 유도된 약물 과민성 반응의 위험을 평가하는 방법 | |
| CN105200151B (zh) | Tcf21基因作为疾病诊断标志物的用途 | |
| CN105112551B (zh) | 检测eps8l3基因表达的试剂在制备骨质疏松症诊断产品中的应用 | |
| JP2011509080A5 (enExample) |